Korean MedTech in Brazil: Unlocking ANVISA Approval with a Brazilian Registration Holder (BRH)

This episode explores the single most critical regulatory requirement for Korean medical device companies entering the Brazilian market: the mandatory appointment of a Brazilian Registration Holder (BRH). We delve into why foreign companies cannot register directly with ANVISA, contrast Brazil's system with Korea's MFDS, and outline the extensive legal and operational responsibilities of a BRH, from registration and GMP inspections to post-market surveillance. Learn why selecting the right local partner is essential for your success in Brazil. Key Questions: - What is a Brazilian Registration Holder (BRH) and why is it mandatory for market entry? - How does Brazil's ANVISA registration process differ from Korea's MFDS system for foreign manufacturers? - Can a Korean medical device company register its product in Brazil without a local representative? - What are the key legal responsibilities of a BRH in Brazil? - How does the BRH manage GMP inspections and post-market surveillance? - Why is cultural and regulatory understanding crucial when selecting a BRH partner? - What are the risks of choosing the wrong local representative in Brazil? Navigating complex markets like Brazil requires expert local knowledge. Pure Global provides end-to-end regulatory solutions for MedTech and IVD companies, acting as your local representative and Brazilian Registration Holder (BRH) to streamline market access. Our team of in-country experts, supported by advanced AI tools, manages everything from initial regulatory strategy and technical dossier submission to post-market surveillance. We bridge the gap between your company and ANVISA, ensuring a compliant and efficient path to market. Contact us at [email protected], visit https://pureglobal.com, or explore our FREE AI tools and database at https://pureglobal.ai.